cas 718635-93-9|| where to buy Tetrabenazine(Racemate)

Produktname:Tetrabenazine(Racemate)

IUPAC Name:9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-one

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge
CM145906-10mg	1-2 Weeks	ƈŮ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 718635-93-9 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:718635-93-9; Molekulare Formel:C19H27NO3; Schmelzpunkt:-; SMILES-Code:O=C(C(CC(C)C)C1)CC2N1CCC3=C2C=C(OC)C(OC)=C3; Dichte:

: Katalognummer:CM145906; Molekulargewicht:317.43; Siedepunkt:; Mdl-Nr.:MFCD00042740; Lagerung:Store at 2-8°C.

: Valbenazine; Neurocrine Biosciences announced interim results from the ongoing open-label KINECT®-HD2 study about INGREZZA® (Valbenazine) capsules when used for the long-term treatment of adults with chorea associated with Huntington's disease (HD). Interim data suggest one-capsule, once-daily INGREZZA improved chorea at the first evaluation at Week 2 with sustained efficacy through Week 50. INGREZZA® (Valbenazine) is the only one-capsule, once-daily selective vesicular monoamine transporter 2 (VMAT2) inhibitor approved by FDA for the treatment of adults with tardive dyskinesia and the treatment of chorea associated with Huntington's disease (HD).
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.